tiprankstipranks
Trending News
More News >
Vaxxinity Inc (VAXX)
OTHER OTC:VAXX
US Market

Vaxxinity Inc (VAXX) Income Statement

Compare
140 Followers

Vaxxinity Inc Income Statement

Last quarter (Q4 2023), Vaxxinity Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Vaxxinity Inc's net income was $-11.39M. See Vaxxinity Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 66.00K$ 557.00K$ 0.00
Gross Profit
$ -2.23M$ -1.68M$ -1.87M$ 505.00K$ -107.00K
Operating Expenses
$ 56.05M$ 74.30M$ 123.20M$ 32.79M$ 13.66M
Depreciation and Amortization
$ 2.23M$ 1.68M$ 1.10M$ 717.00K$ 107.00K
EBITDA
$ -54.00M$ -73.02M$ -135.23M$ -38.06M$ -13.58M
Operating Income
$ -58.28M$ -75.98M$ -125.08M$ -32.28M$ -13.66M
Other Income/Expenses
$ 1.35M$ 757.00K$ -12.10M$ -7.67M$ -502.00K
Pretax Income
$ -56.93K$ -75.22M$ -137.18M$ -39.96M$ -14.16M
Net Income
$ -56.93K$ -75.21M$ -137.18M$ -39.96M$ -14.22M
Per Share Metrics
Basic EPS
$ 0.00$ -0.60$ -1.09$ -0.32$ -0.11
Diluted EPS
$ 0.00$ -0.60$ -1.09$ -0.32$ -0.11
Weighted Average Shares Outstanding
126.51M 125.94M 125.39M 125.45M 125.45M
Weighted Average Shares Outstanding (Diluted)
126.51M 125.94M 125.39M 125.45M 125.45M
Currency in USD

Vaxxinity Inc Earnings and Revenue History